Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 10 - 20 tags : Update save search
CATHAY BANK | UCLA ANDERSON FORECAST U.S.-CHINA ECONOMIC REPORT 2022 FALL UPDATE RELEASED The Influence of Current Events on U.S./China Relations and Economies
Published: 2022-10-20 (Crawled : 01:00) - prnewswire.com
CATY A | $36.0 3.87% 3.72% 320K
|
Finance
|
| O: 0.86%
H: 2.0%
C: 1.24%
report update
DIAMONDROCK HOSPITALITY ANNOUNCES UPDATE ON RECENT OPERATIONS
Published: 2022-10-20 (Crawled : 22:00) - prnewswire.com
DRH | $8.83 0.57% 0.0% 2M
|
Finance
|
| O: 1.15%
H: 3.86%
C: 2.39%
update
RENNOVA HEALTH, INC. PROVIDES Q3 2022 PERFORMANCE UPDATE
Published: 2022-10-20 (Crawled : 14:00) - globenewswire.com
RNVA | $0.0001 0.0% 140M
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
update
BitMine Immersion Technologies, Inc. Announces Entry into Joint Venture, Entry into Line of Credit, Buyout of Hosting Agreement, and Trinidad Operations Update
Published: 2022-10-20 (Crawled : 13:00) - globenewswire.com
CRCW | News | $0.0015 27.78% 8.5M
|
Information
|
| O: 39.68%
H: 0.0%
C: 0.0%
update
Femasys Inc. Provides Strategic Update on its FemaSeed® Pivotal Trial Design to Expedite Clinical Program Advancement
Published: 2022-10-20 (Crawled : 13:00) - globenewswire.com
FEMY | $1.33 1.53% 1.5% 160K
|
Manufacturing
|
| O: -1.69%
H: 6.03%
C: 6.03%
femaseed program trial update
Vaxart to Host Third Quarter 2022 Business Update and Financial Results Conference Call on November 8
Published: 2022-10-20 (Crawled : 13:00) - globenewswire.com
VXRT | News | $0.7652 -9.15% -10.08% 1.9M
|
Health Technology
|
| O: 0.62%
H: 5.56%
C: -0.62%
conference financial update results
MiNK Therapeutics to Report Third Quarter 2022 Financial Results and Business Update
Published: 2022-10-20 (Crawled : 13:00) - globenewswire.com
INKT | $0.898 3.02% 2.93% 40K
|
|
| O: 2.02%
H: 2.48%
C: 2.48%
report therapeutics financial update results
argenx to Report Third Quarter 2022 Financial Results and Business Update on October 27, 2022
Published: 2022-10-20 (Crawled : 07:00) - biospace.com/
ARGX | $360.11 0.47% 0.47% 330K
|
Health Technology
|
| O: -4.1%
H: 4.74%
C: 4.6%
report financial update results
Innate Pharma 2023 Financial Calendar Innate Pharma SA released its 2023 financial calendar. argenx to Report Third Quarter 2022 Financial Results and Business Update on October 27, 2022 argenx announc...
Published: 2022-10-20 (Crawled : 07:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.35%
H: 1.28%
C: -0.17%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.19%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.0%
H: 2.4%
C: 1.92%
DNLI | $15.98 -3.74% -3.88% 1.5M
|
Health Technology
|
| O: -5.24%
H: 10.87%
C: 5.45%
pharma report financial update results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.